Skip to main content

Table 3 Comparison of in vitro drug susceptibility profiles between M. abscessus subspecies abscessus and M. abscessus subspecies massiliense isolates

From: Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013–2016

Antimicrobial agents

No. of resistant isolates (%)

P value

M. abscessus subspecies abscessus (n = 136)

M. abscessus

subspecies massiliense

(n = 95)

Amikacin

3 (2.2)

2 (2.1)

1.000

Clarithromycin

6 (4.4)

3 (3.2)

0.740

Linezolid

6 (4.4)

2 (2.1)

0.476

Tobramycin

6 (4.4)

2 (2.1)

0.476

Cefoxitin

46 (33.8)

24 (25.3)

0.164

Ciprofloxacin

86 (63.2)

68 (71.6)

0.186

Doxycycline

127 (93.4)

94 (98.9)

0.050

Imipenem

134 (98.5)

95 (100.0)

1.000

  1. The breakpoints to establish susceptibility and resistance for drugs were followed as recommendation from Clinical and Laboratory Standards Institute (CLSI-M24-A2)